About Us

Welcome to FesariusTherapeutics - the cutting-edge biotech start-up on a mission to revolutionize the world of regenerative medicine. We are dedicated to developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery.

Founded in 2015, based upon technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine, FesariusTherapeutics has developed DermiSphereTM, a  revolutionary dermal regeneration template (DRT) for the management of wounds.
meet canopy

Design can be time-consuming.
Canopy makes it easy.

Our Mission

At Fesarius, our mission is to optimize solutions for tissue regeneration and repair in areas of highly impactful clinical need. We have developed ground-breaking technologies to revolutionize the treatment of full-thickness skin loss, speeding the process of tissue regeneration and dramatically improving the lives of the patients we serve. We aim to disrupt current paradigms of reconstructive surgery by committing to Quality Science, Compelling Data, and Superior Products developed in partnership with experts in the markets we serve.

At Fesarius, we are driven by a strong sense of purpose and an unwavering commitment
to excellence. Through a focused marketing program and best-in-class distribution channels, we aim to enter each market vertical with a clear strategy and a comprehensive understanding of our customers needs.

Our objective is to support our surgeon partners and healthcare providers by delivering cutting-edge technology, innovative support and unparalleled customer service. We are dedicated to driving positive change in our field and passionate about making a meaningful difference in patients’ lives and improving health outcomes worldwide.
At Fesarius, our mission is to optimize solutions for tissue regeneration and repair in areas of highly impactful clinical need. We have developed ground-breaking technologies to revolutionize the treatment of full-thickness skin loss, speeding the process of tissue regeneration and dramatically improving the lives of the patients we serve. We aim to disrupt current paradigms of reconstructive surgery by committing to Quality Science, Compelling Data, and Superior Products developed in partnership with experts in the markets we serve.

At Fesarius, we are driven by a strong sense of purpose and an unwavering commitmentto excellence. Through a focused marketing program and best-in-class distribution channels, we aim to enter each market vertical with a clear strategy and a comprehensive understanding of our customers needs.

Our objective is to support our surgeon partners and healthcare providers by delivering cutting-edge technology, innovative support and unparalleled customer service. We are dedicated to driving positive change in our field and passionate about making a meaningful difference in patients’ lives and improving health outcomes worldwide.

Meet Our Team

At FesariusTherapeutics, we don’t just develop groundbreaking technologies; we’re on a mission to revolutionize reconstructive and regenerative surgery and improve patients lives across the globe. Our team is a passionate group of trailblazers dedicated to innovation with a proven track record of success.From experienced surgeons to brilliant engineers and industry veteran professionals, our team brings diverse skills and perspectives to the table.
‍
Led by a unique blend of decades of clinical, entrepreneurial, and scientific expertise, our team is committed to working collaboratively to drive radical change in scaffold development for reconstructive surgery. We are dedicated to providing optimal patient care, utilizing innovative engineered solutions and meticulous science to enhance the future of wound care.
‍
We work together seamlessly, constantly pushing the boundaries of what is possible and turning challenges into opportunities. Meet the individuals driving our mission forward and learn about their backgrounds, areas of expertise, and how they contribute to our amazing work.
Dr. Jason Spector
Founder, Director
William G. Mavity
Director
David W. Anderson
Director
Gabor Forgacs, Ph.D
Director
Brett Spector, M.B.A
Director
Tom Roueche
President & CEO, Director
Yulia Sapir-Lekhovitser, Ph.D
Chief Scientific Officer
Brent Atkinson, Ph.D.
Product Development
Sally Maher
Regulatory Affairs
Frank DeLustro, Ph.D
Science & Development Advisor

Our Values

Guided by a set of core values, Fesarius shapes its approach to every endeavor. These values define our culture and serve as a compass, directing our decisions and actions.
Utmost Integrity
Operating with unwavering integrity and ethical standards is fundamental to our business. We prioritize honesty, transparency, and accountability in all interactions with our employees, customers, partners, and stakeholders. Even when faced with challenging choices, we remain committed to doing what is right.
Compassion for patient care
At Fesarius, we recognize that our purpose is centered around improving patients' lives. Therefore, we approach our work with empathy, compassion, and a profound sense of responsibility. We aim to develop medical devices that have a meaningful and enduring impact on patient outcomes and quality of life.
Rigorous science
Upholding the highest standards of scientific rigor is a non-negotiable aspect of our research, development, and manufacturing processes. Our practices rely on evidence-based methodologies, validated approaches, and sound scientific principles. By adhering to these standards, we ensure our medical devices' safety, efficacy, and reliability. We continually strive to advance scientific knowledge and embrace innovation while maintaining robust and rigorous scientific practices.
Diverse culture
At Fesarius, we foster a culture that embraces and values diversity in all its forms. We recognize that diverse perspectives, backgrounds, and experiences lead to enhanced decision-making and innovation. Our goal is to cultivate an inclusive environment where everyone feels respected, empowered, and inspired to contribute their unique talents and ideas. By embracing diversity, we strengthen our ability to address the diverse needs of patients and healthcare providers worldwide.
contact us

We’re here to help.

Learn more about DermiSphereTM and when it will be available on market.
Contact Us

Hello, we’re Canopy.

Adipiscing eget in mattis purus nunc. Sit diam nunc nunc blandit scelerisque et eu. Aliquam nunc aliquet id nullam morbi nisl. Cursus aliquet ut vitae odio. Egestas ornare dis condimentum quis at id velit tellus nibh. Hendrerit tristique in sed.
Tortor semper diam turpis pellentesque tellus sit eget sagittis. Ridiculus cras porttitor hac convallis quisque malesuada. Tellus non nulla in fermentum magna varius sed.
“Canopy isn’t just one or two basic pages, it covers all the bases and allows us to launch fully realised websites faster than ever.️”
Jake Smalls – Designer
“Canopy isn’t just one or two basic pages, it covers all the bases and allows us to launch fully realised websites faster than ever.️”
Hannah Nguyen
Founder & CEO

A little more about us.

Canopy UI Kit is a powerful tool for business owners and entrepreneurs to make the right first impression.
4.98/5
Rating from over 300 verified reviews.
23,438
A five digit number that’s sure to impress.
Be Authentic.
Create your website using purpose-built sections.
Be Inclusive.
Showcase your product with customisable UI Snippets
Share Boldly.
Make it yours with a modular, complete style guide
Make Waves.
Add dynamic content to your site with Webflow CMS features
Heading

Design can be time-consuming.
Canopy makes it easy.

Fesarius Therapeutics demonstrates novel DermiSphere™ hydrogel successfully treats full thickness skin loss in one surgical step

Fesarius Therapeutics demonstrates novel DermiSphere™ hydrogel successfully treats full thickness skin loss in one surgical step

New peer-reviewed study shows a successful reconstruction of full-thickness skin defects in a swine model using simultaneous split-thickness skin grafting and composite collagen microstructured dermal scaffold

New peer-reviewed study shows a successful reconstruction of full-thickness skin defects in a swine model using simultaneous split-thickness skin grafting and composite collagen microstructured dermal scaffold

Fesarius Therapeutics receives prestigious NIH SBIR research grant for DermiSphere™ hydrogel technology to treat full thickness skin loss

Fesarius Therapeutics receives prestigious NIH SBIR research grant for DermiSphere™ hydrogel technology to treat full thickness skin loss

Product
DermiSphere
Company
Who We AreNews & Events
Get in Touch
Contact Us
Follow Us on LinkedIn
© 2023 FesariusTherapeutics Inc. All Rights Reserved.
Designed by Icovy Marketing